Hematologic and hemostatic system

The hematologic and hemostatic system is a complex physiological network responsible for the production of blood components and the regulation of blood flow and clotting. It comprises the bone marrow, where hematopoiesis occurs, and the circulatory system, where platelets and coagulation factors interact to maintain vascular integrity (StatPearls, NBK534811). Hemostasis is a tightly regulated process involving primary hemostasis (platelet plug formation) and secondary hemostasis (the coagulation cascade), balanced by fibrinolysis to prevent excessive clotting (StatPearls, NBK545263). Pathological states arise when this balance is disrupted, leading to either hemorrhage or thrombosis. Therapeutic strategies targeting this system are diverse, ranging from anticoagulants and antiplatelet agents to growth factors that stimulate the production of specific blood cell lineages (NIH, Blood Disorders). This system also plays a vital role in the immune response through the action of leukocytes and inflammatory mediators (PubMed, 28637619).

Other names

Hematopoietic systemHemostasis systemBlood and coagulation system

As a physiological system rather than a single molecule, the mechanisms of action for drugs interacting with its components vary widely, including the inhibition of coagulation factors (e.g., thrombin or Factor Xa), inhibition of platelet aggregation (e.g., P2Y12 antagonism), and stimulation of hematopoietic receptors (e.g., erythropoietin receptor) (StatPearls, NBK545263; NIH, Blood Disorders).